GLP-1

5 names · equal weight

AlfaCat GLP-1: 5 names tied to the weight-loss and diabetes drugs, equally weighted — the makers with drugs on the market, the companies with one in trials, and a telehealth seller. A study view, not a list of picks.

Today
-3.34%
1 year
-10.01%
S&P 500, 1 year
+4.89%
12910081
Nov ’25Feb ’26May ’26Aug ’26Nov ’26
AlfaCat GLP-1Nasdaq 100S&P 500each line starts at 100

How broad

of 5 names
Above 50-day average
2 of 5
Within 5% of 52w high
0 of 5
RSI 70 or above
0
RSI 30 or below
1

Who moved it today

share of -3.34%, in points

On the market

today -1.50% · YTD -0.20%
SymbolPrice1DYTDP/E
LLY
Eli Lilly
$1,347-0.30%+25.30%46.1
NVO
Novo Nordisk
$37.82-2.70%-25.70%10.1

In trials

today -2.43% · YTD +1.75%
SymbolPrice1DYTDP/E
AMGN
Amgen
$435.64-0.72%+33.10%25.1
VKTX
Viking Therapeutics
$24.77-4.14%-29.60%—

Telehealth

today -8.86% · YTD -55.00%
SymbolPrice1DYTDP/E
HIMS
Hims & Hers Health
$14.60-8.86%-55.00%26.7

What it is priced at

median P/E
This basket
25.9
S&P 500
22.0

Medians of the names that report a positive P/E — 4 of 5 here. A median is not the index's own P/E; it shows where the typical member sits.

Reporting next

none in 60 days

Equal-weight baskets chosen by AlfaCat from the instruments it follows. Information, not investment advice.

Download on theApp Store Get it onGoogle Play